HEC Pharm Awaits Fate As Novartis Petitions On US Gilenya Victory

Credit Suisse: High Probability Of 2024 Delay

 
• By Dean Rudge
  
US flag gavel (Andriy Popov/Alamy Stock Photo)
Novartis is guiding for 2024 generic entry • Source: Shutterstock (Andriy Popov / Alamy Stock Photo/Alamy Stock Photo)

More from Generics

More from Products